EMAIL THIS PAGE TO A FRIEND

PloS one

Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata.


PMID 26327534

Abstract

Antrodia camphorata is a well-known medicinal mushroom in Taiwan and has been studied for decades, especially with focus on anti-cancer activity. Polysaccharides are the major bioactive compounds reported with anti-cancer activity, but the debates on how they target cells still remain. Research addressing the encapsulation of polysaccharides from A. camphorata extract (ACE) to enhance anti-cancer activity is rare. In this study, ACE polysaccharides were nano-encapsulated in chitosan-silica and silica (expressed as ACE/CS and ACE/S, respectively) to evaluate the apoptosis effect on a hepatoma cell line (Hep G2). The results showed that ACE polysaccharides, ACE/CS and ACE/S all could damage the Hep G2 cell membrane and cause cell death, especially in the ACE/CS group. In apoptosis assays, DNA fragmentation and sub-G1 phase populations were increased, and the mitochondrial membrane potential decreased significantly after treatments. ACE/CS and ACE/S could also increase reactive oxygen species (ROS) generation, induce Fas/APO-1 (apoptosis antigen 1) expression and elevate the proteolytic activities of caspase-3, caspase-8 and caspase-9 in Hep G2 cells. Unsurprisingly, ACE/CS induced a similar apoptosis mechanism at a lower dosage (ACE polysaccharides = 13.2 μg/mL) than those of ACE/S (ACE polysaccharides = 21.2 μg/mL) and ACE polysaccharides (25 μg/mL). Therefore, the encapsulation of ACE polysaccharides by chitosan-silica nanoparticles may provide a viable approach for enhancing anti-tumor efficacy in liver cancer cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A8380
5α-Androstan-17β-ol-3-one, ≥97.5%
C19H30O2
45726
Acetic acid, for luminescence, BioUltra, ≥99.5% (GC)
C2H4O2
W200603
Acetic acid, natural, ≥99.5%, FG
C2H4O2
W200611
Acetic acid, ≥99.5%, FCC, FG
C2H4O2
ARK2183
Acetic acid, glacial, PharmaGrade, USP, JP, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C2H4O2
606766
Acetic acid-12C2, 99.9 atom % 12C
12C2H4O2
46955
Fluorescein, for fluorescence, free acid
C20H12O5
A9967
Glacial acetic acid, meets USP testing specifications
C2H4O2
P0838
Potassium bromide, BioXtra, ≥99.0%
BrK
449962
Potassium bromide, anhydrous, powder, 99.999% trace metals basis
BrK
451010
Potassium bromide, anhydrous, powder, 99.95% trace metals basis
BrK
449970
Potassium bromide, anhydrous, beads, −10 mesh, ≥99.9% trace metals basis
BrK
229792
Potassium bromide, 99.99% trace metals basis
BrK
60089
Potassium bromide, BioUltra, ≥99.5% (AT)
BrK
S2889
Sodium acetate, anhydrous, for molecular biology, ≥99%
C2H3NaO2
S3272
Sodium acetate, for electrophoresis, ≥99%, crystalline
C2H3NaO2
S5636
Sodium acetate, powder, BioReagent, for electrophoresis, suitable for cell culture, suitable for insect cell culture, ≥99%
C2H3NaO2
S1429
Sodium acetate, meets USP testing specifications, anhydrous
C2H3NaO2
229873
Sodium acetate, 99.995% trace metals basis
C2H3NaO2
S7545
Sodium acetate, BioXtra, ≥99.0%
C2H3NaO2
71183
Sodium acetate, anhydrous, BioUltra, for luminescence, for molecular biology, ≥99.0% (NT)
C2H3NaO2
W302406
Sodium Acetate Anhydrous, >99%, FCC, FG
C2H3NaO2
S8388
Sodium acetate solution, 0.3 M
C2H3NaO2
71196
Sodium acetate solution, BioUltra, for molecular biology, ~3 M in H2O
C2H3NaO2
342483
Sodium phosphate, 96%
Na3O4P